← Evidence map

ArticleGut2017

The safety of vedolizumab for ulcerative colitis and Crohn's disease.

Jean-Frédéric Colombel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

390 papers cite itlatest 60 shown

2017
…
2021
2022
2024
2025
2026
this paperpooled ittrialcites it

6 trials

Full record →Abstract, authors, funding and every citing paper · PMID 26893500